Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions

Pillai, Unni S; Kayal, Smita; Cyriac, Sunu; Nisha, Yadav; Dharanipragada, Kadambari; Kamalanathan, Sadish Kumar; Halanaik, Dhanapathi; Kumar, Navin; Madasamy, Ponraj; Muniswamy, Dhanraju Krishnappa; Dubashi, Biswajit

doi:10.31557/APJCP.2019.20.9.2673

Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions

Document Type : Research Articles

Authors

¹ Department of Medical Oncology, Jawaharlal Institute of Post Graduate Medical Education & Research (JIPMER), Puducherry, India.

² Department of Surgery, Jawaharlal Institute of Post Graduate Medical Education & Research (JIPMER), Puducherry, India.

³ Department of Endocrinology, Jawaharlal Institute of Post Graduate Medical Education & Research (JIPMER), Puducherry, India.

⁴ Department of Nuclear Medicine,Jawaharlal Institute of Post Graduate Medical Education & Research (JIPMER), Puducherry, India.

⁵ Department of Physiology, Jawaharlal Institute of Post Graduate Medical Education & Research (JIPMER), Puducherry, India.

10.31557/APJCP.2019.20.9.2673

Abstract

Purpose: To study the late toxicities of treatment and its impact on Breast cancer survivors among Indian patients.
Materials and Methods: Our study recruited 152 curatively treated non metastatic carcinoma breast patients. The
baseline demographic details, disease related and treatment related information were collected. The late effects included
breast cancer related lymphedema, shoulder dysfunction, treatment induced bone loss, hypothyroidism, cardiac
dysfunction, and chemotherapy induced cognitive dysfunction and Quality of life. Results: The median age was 47
years (range 27 -72 years). The cumulative frequency of BCRL and shoulder dysfunction was 31.57% and 34.86%
respectively. The improvement in BCRL with corrective intervention was not statistically significant. The BCRL was
significantly associated with shoulder dysfunction. The frequency of loss of bone mineral density was 38.15%. There was
statistically significant improvement in bone mineral density with interventions. The cumulative rate of hypothyroidism
and cardiac dysfunction was 14.47 % and 2.17% respectively which improved after corrective therapy. We did not find
any delayed cognitive dysfunction. There was improvement in global health, physical function, role function, fatigue,
Nausea, vomiting, pain scores, insomnia, Loss of appetite, diarrhea and arm symptoms over time with intervention.
Conclusion: Our study has shown that nearly half of the survivors were suffering from at least one of the late effects.
The intervention helped in improving the loss of bone mineral density, hypothyroidism, cardiac dysfunction and quality
of life in Breast cancer survivors.

Keywords

Main Subjects